European Archives - Page 923 of 1125 - European Medical Journal

Continue
1 Mins
8 Jun 2017

Adenosine 2A Receptor Stimulation Prevents the Multiple Processes That Lead to Hepatic 'Immuno-Lipotoxicity' in Mice Fed a Methionine Choline-Deficient Diet and Blocks Non-Alcoholic Steatohepatitis Development

Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but in ~20% of patients it can evolve into non-alcoholic steatohepatitis (NASH) with…
4 Mins
8 Jun 2017

Beta-Blockers in Prevention of Development of Varices and Variceal Bleeding in Cirrhosis: Current Management, Controversies, and Future Directions

One of the major complications of cirrhosis is the development of portal hypertension and variceal bleeding. Varices develop at a rate of 5% per year…
1 Mins
8 Jun 2017

A New Screening Strategy for Varices by Liver and Spleen Stiffness Measurements in Cirrhotic Patients: A Randomised Controlled Trial

Variceal screening with upper endoscopy is recommended in cirrhotic patients but unfortunately is costly, uncomfortable to patients, and has low uptake.
8 Mins
8 Jun 2017

Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology

This review will cover the epidemiology, risk factors, pathogenesis, and pathology of hepatocellular carcinoma (HCC).
9 Mins
8 Jun 2017

Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis

Clinical presentation of hepatocellular carcinoma (HCC) can vary from asymptomatic patients to patients presenting variable symptoms such as pain, lethargy…
2 Mins
8 Jun 2017

Predicting Severe Liver Disease in the General Population: Abdominal Obesity, Insulin Resistance, Diabetes, Cholesterol, and Alcohol

Liver disease is the 13th leading cause of death worldwide, and hepatocellular carcinoma is the 2nd leading cause of cancer death. Finland has one of the…
11 Mins
8 Jun 2017

Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment

Hepatocellular carcinoma (HCC) treatment is variable and depends on the size, location, and presence of extra hepatic metastasis and vascular invasion.
1 Mins
8 Jun 2017

Japanese Guidelines and Real-World Data on the Management of Hepatitis C

The guideline committee of the Japan Society of Hepatology (JSH) have promptly updated the treatment guideline for the hepatitis C virus (HCV) after…
9 Mins
8 Jun 2017

A Look at Platelet Count in Chronic Hepatitis C Infection

Many complications can occur during the evolution of chronic Hepatitis C virus (HCV) infection. Some of them can be…
2 Mins
8 Jun 2017

What is the Role of Ursodeoxycholic Acid for the Future Management of Patients with Primary Sclerosing Cholangitis in the Clinic and in Trials?

Primary sclerosing cholangitis (PSC) is a rare, progressive, cholestatic, immune-mediated hepatobiliary disease. It is characterised by inflammation…
We’ve noticed you’re accessing
from North/South America.